- Telehealth Visits
- Insurance plan information
Aaron C. Logan, MD, PhD
Leukemia • Hematology Oncology- Telehealth Visits
- Insurance plan information
Aaron C. Logan, MD, PhD
Leukemia • Hematology Oncology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Hematology, American Board of Internal Medicine/Hematology
Fellowship
- Hematology, Stanford University Blood & Marrow Transplant GME
Residency
- Internal Medicine, Stanford University Internal Medicine Residency
Internship
- Stanford University Internal Medicine Residency
Degree
- MD, Keck School of Medicine at USC
My expertise
Specialties
- Leukemia
- Hematology Oncology
- Hematology
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222038%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222038%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 29 reviews
- November 22, 20255 out of 5 Stars
Good
- November 7, 20255 out of 5 Stars
Dr. Logan is very down-to-earth and accessible. He instills confidence.
- November 7, 20255 out of 5 Stars
My oncologist addresses my needs, attentively. He is personable and approachable.
- November 1, 20255 out of 5 Stars
I have seen several doctors and Dr Aaron Logan is the best. He listens and answers my questions in detail in a manner that I can understand. He is also patient at explaining medical information. Best of all, he is a kind man with a good sense of humor.
- September 29, 20255 out of 5 Stars
Dr. Logan is great!
- September 5, 20255 out of 5 Stars
Dr. Logan should be a recipient of Nobel Price for Blood Cancer.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.